Causal claim
The two move together: more cause, more effect. The map scores it at 36% confidence, weighed from 2 articles.
uniQure's HD gene therapy program advances toward regulatory submission following FDA switchup
uniQure will seek approval for Huntington's disease gene therapy after switchup...
drugdiscoverynews.com · Jun 19, 2026 Standard
UniQure to seek approval of Huntington’s gene therapy after FDA U-turn - Pharmaceutical Technology
pharmaceutical-technology.com · Jun 18, 2026 Standard
See it on the live map →